ArticleAlzheimer's & dementia (New York, N. Y.)2015

A phase 1 study to evaluate the safety and pharmacokinetics of PQ912, a glutaminyl cyclase inhibitor, in healthy subjects.

Inge Lues et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.